Custom Monoclonal Antibody Development Services- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031

TABLE OF CONTENTS

1 Market Overview

• 1.1 Custom Monoclonal Antibody Development Services Product Introduction
• 1.2 Global Custom Monoclonal Antibody Development Services Market Size Forecast (2020-2031)
• 1.3 Custom Monoclonal Antibody Development Services Market Trends & Drivers
  • 1.3.1 Custom Monoclonal Antibody Development Services Industry Trends
  • 1.3.2 Custom Monoclonal Antibody Development Services Market Drivers & Opportunity
  • 1.3.3 Custom Monoclonal Antibody Development Services Market Challenges
  • 1.3.4 Custom Monoclonal Antibody Development Services Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Custom Monoclonal Antibody Development Services Players Revenue Ranking (2024)
• 2.2 Global Custom Monoclonal Antibody Development Services Revenue by Company (2020-2025)
• 2.3 Key Companies Custom Monoclonal Antibody Development Services Manufacturing Base Distribution and Headquarters
• 2.4 Key Companies Custom Monoclonal Antibody Development Services Product Offered
• 2.5 Key Companies Time to Begin Mass Production of Custom Monoclonal Antibody Development Services
• 2.6 Custom Monoclonal Antibody Development Services Market Competitive Analysis
  • 2.6.1 Custom Monoclonal Antibody Development Services Market Concentration Rate (2020-2025)
  • 2.6.2 Global 5 and 10 Largest Companies by Custom Monoclonal Antibody Development Services Revenue in 2024
  • 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Monoclonal Antibody Development Services as of 2024)
• 2.7 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Based on the Host Animal
  • 3.1.2 Based on the Technology Platform
• 3.2 Global Custom Monoclonal Antibody Development Services Sales Value by Type
  • 3.2.1 Global Custom Monoclonal Antibody Development Services Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Custom Monoclonal Antibody Development Services Sales Value, by Type (2020-2031)
  • 3.2.3 Global Custom Monoclonal Antibody Development Services Sales Value, by Type (%) (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Biomedical Research
  • 4.1.2 Diagnostics
  • 4.1.3 Others
• 4.2 Global Custom Monoclonal Antibody Development Services Sales Value by Application
  • 4.2.1 Global Custom Monoclonal Antibody Development Services Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Custom Monoclonal Antibody Development Services Sales Value, by Application (2020-2031)
  • 4.2.3 Global Custom Monoclonal Antibody Development Services Sales Value, by Application (%) (2020-2031)

5 Segmentation by Region

• 5.1 Global Custom Monoclonal Antibody Development Services Sales Value by Region
  • 5.1.1 Global Custom Monoclonal Antibody Development Services Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Custom Monoclonal Antibody Development Services Sales Value by Region (2020-2025)
  • 5.1.3 Global Custom Monoclonal Antibody Development Services Sales Value by Region (2026-2031)
  • 5.1.4 Global Custom Monoclonal Antibody Development Services Sales Value by Region (%), (2020-2031)
• 5.2 North America
  • 5.2.1 North America Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 5.2.2 North America Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031
• 5.3 Europe
  • 5.3.1 Europe Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 5.3.2 Europe Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031
• 5.4 Asia Pacific
  • 5.4.1 Asia Pacific Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 5.4.2 Asia Pacific Custom Monoclonal Antibody Development Services Sales Value by Region (%), 2024 VS 2031
• 5.5 South America
  • 5.5.1 South America Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 5.5.2 South America Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031
• 5.6 Middle East & Africa
  • 5.6.1 Middle East & Africa Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 5.6.2 Middle East & Africa Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
• 6.3 United States
  • 6.3.1 United States Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.3.2 United States Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.4.2 Europe Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.5.2 China Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.6.2 Japan Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.7.2 South Korea Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Custom Monoclonal Antibody Development Services Sales Value, 2020-2031
  • 6.9.2 India Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Custom Monoclonal Antibody Development Services Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 GenScript
  • 7.1.1 GenScript Profile
  • 7.1.2 GenScript Main Business
  • 7.1.3 GenScript Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.1.4 GenScript Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.1.5 GenScript Recent Developments
• 7.2 Sino Biological
  • 7.2.1 Sino Biological Profile
  • 7.2.2 Sino Biological Main Business
  • 7.2.3 Sino Biological Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.2.4 Sino Biological Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.2.5 Sino Biological Recent Developments
• 7.3 R&D Systems
  • 7.3.1 R&D Systems Profile
  • 7.3.2 R&D Systems Main Business
  • 7.3.3 R&D Systems Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.3.4 R&D Systems Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.3.5 R&D Systems Recent Developments
• 7.4 Thermo Fisher Scientific Inc
  • 7.4.1 Thermo Fisher Scientific Inc Profile
  • 7.4.2 Thermo Fisher Scientific Inc Main Business
  • 7.4.3 Thermo Fisher Scientific Inc Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.4.4 Thermo Fisher Scientific Inc Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.4.5 Thermo Fisher Scientific Inc Recent Developments
• 7.5 CDI Labs
  • 7.5.1 CDI Labs Profile
  • 7.5.2 CDI Labs Main Business
  • 7.5.3 CDI Labs Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.5.4 CDI Labs Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.5.5 CDI Labs Recent Developments
• 7.6 ProteoGenix
  • 7.6.1 ProteoGenix Profile
  • 7.6.2 ProteoGenix Main Business
  • 7.6.3 ProteoGenix Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.6.4 ProteoGenix Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.6.5 ProteoGenix Recent Developments
• 7.7 Bio-Techne
  • 7.7.1 Bio-Techne Profile
  • 7.7.2 Bio-Techne Main Business
  • 7.7.3 Bio-Techne Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.7.4 Bio-Techne Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.7.5 Bio-Techne Recent Developments
• 7.8 Eurogentec
  • 7.8.1 Eurogentec Profile
  • 7.8.2 Eurogentec Main Business
  • 7.8.3 Eurogentec Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.8.4 Eurogentec Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.8.5 Eurogentec Recent Developments
• 7.9 BioGenes GmbH
  • 7.9.1 BioGenes GmbH Profile
  • 7.9.2 BioGenes GmbH Main Business
  • 7.9.3 BioGenes GmbH Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.9.4 BioGenes GmbH Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.9.5 BioGenes GmbH Recent Developments
• 7.10 BBI Solutions
  • 7.10.1 BBI Solutions Profile
  • 7.10.2 BBI Solutions Main Business
  • 7.10.3 BBI Solutions Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.10.4 BBI Solutions Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.10.5 BBI Solutions Recent Developments
• 7.11 Immunostep
  • 7.11.1 Immunostep Profile
  • 7.11.2 Immunostep Main Business
  • 7.11.3 Immunostep Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.11.4 Immunostep Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.11.5 Immunostep Recent Developments
• 7.12 Fortis Life Sciences
  • 7.12.1 Fortis Life Sciences Profile
  • 7.12.2 Fortis Life Sciences Main Business
  • 7.12.3 Fortis Life Sciences Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.12.4 Fortis Life Sciences Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.12.5 Fortis Life Sciences Recent Developments
• 7.13 ProMab
  • 7.13.1 ProMab Profile
  • 7.13.2 ProMab Main Business
  • 7.13.3 ProMab Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.13.4 ProMab Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.13.5 ProMab Recent Developments
• 7.14 OriGene
  • 7.14.1 OriGene Profile
  • 7.14.2 OriGene Main Business
  • 7.14.3 OriGene Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.14.4 OriGene Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.14.5 OriGene Recent Developments
• 7.15 Biocompare
  • 7.15.1 Biocompare Profile
  • 7.15.2 Biocompare Main Business
  • 7.15.3 Biocompare Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.15.4 Biocompare Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.15.5 Biocompare Recent Developments
• 7.16 Precision Antibody
  • 7.16.1 Precision Antibody Profile
  • 7.16.2 Precision Antibody Main Business
  • 7.16.3 Precision Antibody Custom Monoclonal Antibody Development Services Products, Services and Solutions
  • 7.16.4 Precision Antibody Custom Monoclonal Antibody Development Services Revenue (US$ Million) & (2020-2025)
  • 7.16.5 Precision Antibody Recent Developments

8 Industry Chain Analysis

• 8.1 Custom Monoclonal Antibody Development Services Industrial Chain
• 8.2 Custom Monoclonal Antibody Development Services Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Custom Monoclonal Antibody Development Services Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Custom Monoclonal Antibody Development Services Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer

List of Tables

Table 1. Custom Monoclonal Antibody Development Services Market Trends

Table 2. Custom Monoclonal Antibody Development Services Market Drivers & Opportunity

Table 3. Custom Monoclonal Antibody Development Services Market Challenges

Table 4. Custom Monoclonal Antibody Development Services Market Restraints

Table 5. Global Custom Monoclonal Antibody Development Services Revenue by Company (2020-2025) & (US$ Million)

Table 6. Global Custom Monoclonal Antibody Development Services Revenue Market Share by Company (2020-2025)

Table 7. Key Companies Custom Monoclonal Antibody Development Services Manufacturing Base Distribution and Headquarters

Table 8. Key Companies Custom Monoclonal Antibody Development Services Product Type

Table 9. Key Companies Time to Begin Mass Production of Custom Monoclonal Antibody Development Services

Table 10. Global Custom Monoclonal Antibody Development Services Companies Market Concentration Ratio (CR5 and HHI)

Table 11. Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Custom Monoclonal Antibody Development Services as of 2024)

Table 12. Mergers & Acquisitions, Expansion Plans

Table 13. Global Custom Monoclonal Antibody Development Services Sales Value by Type: 2020 VS 2024 VS 2031 (US$ Million)

Table 14. Global Custom Monoclonal Antibody Development Services Sales Value by Type (2020-2025) & (US$ Million)

Table 15. Global Custom Monoclonal Antibody Development Services Sales Value by Type (2026-2031) & (US$ Million)

Table 16. Global Custom Monoclonal Antibody Development Services Sales Market Share in Value by Type (2020-2025)

Table 17. Global Custom Monoclonal Antibody Development Services Sales Market Share in Value by Type (2026-2031)

Table 18. Global Custom Monoclonal Antibody Development Services Sales Value by Application: 2020 VS 2024 VS 2031 (US$ Million)

Table 19. Global Custom Monoclonal Antibody Development Services Sales Value by Application (2020-2025) & (US$ Million)

Table 20. Global Custom Monoclonal Antibody Development Services Sales Value by Application (2026-2031) & (US$ Million)

Table 21. Global Custom Monoclonal Antibody Development Services Sales Market Share in Value by Application (2020-2025)

Table 22. Global Custom Monoclonal Antibody Development Services Sales Market Share in Value by Application (2026-2031)

Table 23. Global Custom Monoclonal Antibody Development Services Sales Value by Region, (2020 VS 2024 VS 2031) & (US$ Million)

Table 24. Global Custom Monoclonal Antibody Development Services Sales Value by Region (2020-2025) & (US$ Million)

Table 25. Global Custom Monoclonal Antibody Development Services Sales Value by Region (2026-2031) & (US$ Million)

Table 26. Global Custom Monoclonal Antibody Development Services Sales Value by Region (2020-2025) & (%)

Table 27. Global Custom Monoclonal Antibody Development Services Sales Value by Region (2026-2031) & (%)

Table 28. Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value Growth Trends, (US$ Million): 2020 VS 2024 VS 2031

Table 29. Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value, (2020-2025) & (US$ Million)

Table 30. Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value, (2026-2031) & (US$ Million)

Table 31. GenScript Basic Information List

Table 32. GenScript Description and Business Overview

Table 33. GenScript Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 34. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of GenScript (2020-2025)

Table 35. GenScript Recent Developments

Table 36. Sino Biological Basic Information List

Table 37. Sino Biological Description and Business Overview

Table 38. Sino Biological Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 39. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Sino Biological (2020-2025)

Table 40. Sino Biological Recent Developments

Table 41. R&D Systems Basic Information List

Table 42. R&D Systems Description and Business Overview

Table 43. R&D Systems Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 44. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of R&D Systems (2020-2025)

Table 45. R&D Systems Recent Developments

Table 46. Thermo Fisher Scientific Inc Basic Information List

Table 47. Thermo Fisher Scientific Inc Description and Business Overview

Table 48. Thermo Fisher Scientific Inc Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 49. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Thermo Fisher Scientific Inc (2020-2025)

Table 50. Thermo Fisher Scientific Inc Recent Developments

Table 51. CDI Labs Basic Information List

Table 52. CDI Labs Description and Business Overview

Table 53. CDI Labs Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 54. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of CDI Labs (2020-2025)

Table 55. CDI Labs Recent Developments

Table 56. ProteoGenix Basic Information List

Table 57. ProteoGenix Description and Business Overview

Table 58. ProteoGenix Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 59. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of ProteoGenix (2020-2025)

Table 60. ProteoGenix Recent Developments

Table 61. Bio-Techne Basic Information List

Table 62. Bio-Techne Description and Business Overview

Table 63. Bio-Techne Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 64. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Bio-Techne (2020-2025)

Table 65. Bio-Techne Recent Developments

Table 66. Eurogentec Basic Information List

Table 67. Eurogentec Description and Business Overview

Table 68. Eurogentec Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 69. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Eurogentec (2020-2025)

Table 70. Eurogentec Recent Developments

Table 71. BioGenes GmbH Basic Information List

Table 72. BioGenes GmbH Description and Business Overview

Table 73. BioGenes GmbH Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 74. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of BioGenes GmbH (2020-2025)

Table 75. BioGenes GmbH Recent Developments

Table 76. BBI Solutions Basic Information List

Table 77. BBI Solutions Description and Business Overview

Table 78. BBI Solutions Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 79. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of BBI Solutions (2020-2025)

Table 80. BBI Solutions Recent Developments

Table 81. Immunostep Basic Information List

Table 82. Immunostep Description and Business Overview

Table 83. Immunostep Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 84. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Immunostep (2020-2025)

Table 85. Immunostep Recent Developments

Table 86. Fortis Life Sciences Basic Information List

Table 87. Fortis Life Sciences Description and Business Overview

Table 88. Fortis Life Sciences Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 89. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Fortis Life Sciences (2020-2025)

Table 90. Fortis Life Sciences Recent Developments

Table 91. ProMab Basic Information List

Table 92. ProMab Description and Business Overview

Table 93. ProMab Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 94. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of ProMab (2020-2025)

Table 95. ProMab Recent Developments

Table 96. OriGene Basic Information List

Table 97. OriGene Description and Business Overview

Table 98. OriGene Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 99. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of OriGene (2020-2025)

Table 100. OriGene Recent Developments

Table 101. Biocompare Basic Information List

Table 102. Biocompare Description and Business Overview

Table 103. Biocompare Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 104. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Biocompare (2020-2025)

Table 105. Biocompare Recent Developments

Table 106. Precision Antibody Basic Information List

Table 107. Precision Antibody Description and Business Overview

Table 108. Precision Antibody Custom Monoclonal Antibody Development Services Products, Services and Solutions

Table 109. Revenue (US$ Million) in Custom Monoclonal Antibody Development Services Business of Precision Antibody (2020-2025)

Table 110. Precision Antibody Recent Developments

Table 111. Key Raw Materials Lists

Table 112. Raw Materials Key Suppliers Lists

Table 113. Custom Monoclonal Antibody Development Services Downstream Customers

Table 114. Custom Monoclonal Antibody Development Services Distributors List

Table 115. Research Programs/Design for This Report

Table 116. Key Data Information from Secondary Sources

Table 117. Key Data Information from Primary Sources

List of Figures

Figure 1. Custom Monoclonal Antibody Development Services Product Picture

Figure 2. Global Custom Monoclonal Antibody Development Services Sales Value, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Global Custom Monoclonal Antibody Development Services Sales Value (2020-2031) & (US$ Million)

Figure 4. Custom Monoclonal Antibody Development Services Report Years Considered

Figure 5. Global Custom Monoclonal Antibody Development Services Players Revenue Ranking (2024) & (US$ Million)

Figure 6. The 5 and 10 Largest Companies in the World: Market Share by Custom Monoclonal Antibody Development Services Revenue in 2024

Figure 7. Custom Monoclonal Antibody Development Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 8. Based on the Host Animal Picture

Figure 9. Based on the Technology Platform Picture

Figure 10. Global Custom Monoclonal Antibody Development Services Sales Value by Type (2020 VS 2024 VS 2031) & (US$ Million)

Figure 11. Global Custom Monoclonal Antibody Development Services Sales Value Market Share by Type, 2024 & 2031

Figure 12. Product Picture of Biomedical Research

Figure 13. Product Picture of Diagnostics

Figure 14. Product Picture of Others

Figure 15. Global Custom Monoclonal Antibody Development Services Sales Value by Application (2020 VS 2024 VS 2031) & (US$ Million)

Figure 16. Global Custom Monoclonal Antibody Development Services Sales Value Market Share by Application, 2024 & 2031

Figure 17. North America Custom Monoclonal Antibody Development Services Sales Value (2020-2031) & (US$ Million)

Figure 18. North America Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031

Figure 19. Europe Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 20. Europe Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031

Figure 21. Asia Pacific Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 22. Asia Pacific Custom Monoclonal Antibody Development Services Sales Value by Region (%), 2024 VS 2031

Figure 23. South America Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 24. South America Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031

Figure 25. Middle East & Africa Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 26. Middle East & Africa Custom Monoclonal Antibody Development Services Sales Value by Country (%), 2024 VS 2031

Figure 27. Key Countries/Regions Custom Monoclonal Antibody Development Services Sales Value (%), (2020-2031)

Figure 28. United States Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 29. United States Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 30. United States Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 31. Europe Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 32. Europe Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 33. Europe Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 34. China Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 35. China Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 36. China Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 37. Japan Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 38. Japan Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 39. Japan Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 40. South Korea Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 41. South Korea Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 42. South Korea Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 43. Southeast Asia Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 44. Southeast Asia Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 45. Southeast Asia Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 46. India Custom Monoclonal Antibody Development Services Sales Value, (2020-2031) & (US$ Million)

Figure 47. India Custom Monoclonal Antibody Development Services Sales Value by Type (%), 2024 VS 2031

Figure 48. India Custom Monoclonal Antibody Development Services Sales Value by Application (%), 2024 VS 2031

Figure 49. Custom Monoclonal Antibody Development Services Industrial Chain

Figure 50. Custom Monoclonal Antibody Development Services Manufacturing Cost Structure

Figure 51. Channels of Distribution (Direct Sales, and Distribution)

Figure 52. Bottom-up and Top-down Approaches for This Report

Figure 53. Data Triangulation

Figure 54. Key Executives Interviewed